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A one-pot, three-step process for the
diastereoselective synthesis of
aminobicyclo[4.3.0]nonanes using consecutive
palladium(II)- and ruthenium(II)-catalysis†
Mohamed A. B. Mostafa, Mark. W. Grafton, Claire Wilson and Andrew Sutherland*
A diastereoselective synthesis of highly substituted aminobicyclo[4.3.0]nonanes has been attained using a
one-pot multi-bond forming process. A four-step synthetic route was developed for the efficient syn-
thesis of a series of C-7 substituted hept-2-en-6-yn-1-ols. These compounds were then investigated as
substrates for a one-pot, three-step tandem process involving a palladium(II)-catalysed Overman
rearrangement, a ruthenium(II)-catalysed ring closing enyne metathesis reaction followed by a hydrogen
bond directed Diels–Alder reaction. The optimisation of the one-pot process has allowed the rapid prepa-
ration of a library of aminobicyclo[4.3.0]nonanes with significant molecular complexity and up to four
stereogenic centres.
Introduction
A recent trend in identifying lead-hit compounds and small-
molecule probes for medicinal chemistry and chemical biology
has been the replacement of sp2-rich aromatic and hetero-
aromatic compounds with sp3-rich compounds.1 Partially satu-
rated compounds with a higher degree of saturation have more
suitable physicochemical properties such as solubility and
allow a more efficient examination of three-dimensional
chemical space.1,2 In this regard, saturated and partially satu-
rated forms of amino substituted bicyclo[4.3.0]nonanes have
exhibited wide-ranging biological and pharmacological pro-
perties.3 In particular, these compounds are found as com-
ponents of natural products such as the guanidine alkaloid
netamine A (1)4 and the antitumour antibiotic (+)-ptilocaulin
(2) (Fig. 1).5 Amino-indanes are found as constituents of a
range of medicinal agents including (+)-indatraline (3),6 a
monoamine transporter inhibitor and rasagiline (Azilect), a
drug used for the treatment of Parkinson’s disease.7 Other
amino-indane structural analogues can inhibit the prolifer-
ation of malignant cells8 and are used to treat HIV infections
and AIDS.9
Due to these wide-ranging pharmacological activities, a
number of synthetic approaches have been developed for the
general preparation of these compounds.5,10–13 Diastereo-
selective syntheses have been achieved using an intra-
molecular 1,3-dipolar cycloaddition between an oxime and a
cyclohexene5 and, using a Ru(I)-catalysed allenic cycloisomeri-
sation of an alkynone, followed by a Diels–Alder reaction
of the resulting 2-alkylidene-3-vinylcyclopentenone.10 Other
diastereoselective syntheses include the C–H activation of a
hexahydroindene that gave the corresponding secondary
organoborane, which was then aminated to give the amino
substituted bicyclo[4.3.0]nonane in good overall yield.11
As part of a research programme to develop new methods
for rapid access to drug-like polycyclic scaffolds, we recently
reported the diastereoselective synthesis of amino substituted
bicyclo[4.3.0]nonanes using a one-pot multistep process involv-
ing a thermally-mediated Overman rearrangement of alkyne
derived allylic alcohols, followed by a ring closing enyne
Fig. 1 Biologically active amino bicyclo[4.3.0]nonanes and indanes.
†Electronic supplementary information (ESI) available: NOE data for com-
pounds 25–37 and, 1H and 13C NMR spectra of all new compounds. CCDC
1429493. For ESI and crystallographic data in CIF or other electronic format see
DOI: 10.1039/c6ob00165c
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metathesis (RCEYM) reaction of the resulting enyne and a
hydrogen bond directed Diels–Alder reaction (Scheme 1).14
Using a range of dienophiles, this allowed the late-stage syn-
thesis of a library of partially saturated indane ring systems.
More recently the one-pot method has been extended to
include a cross-metathesis step leading to the rapid prepa-
ration of C-4 substituted analogues with up to five stereogenic
centres.15 While this approach permitted the facile preparation
of a range of amino substituted bicyclo[4.3.0]nonanes, we
found that some of the one-pot processes required particularly
long reaction times and this was in part due to using thermal
conditions to implement the Overman rearrangement
(36 h).14,15 In previous studies, we found that alkene and
alkyne derived allylic trichloroacetimidates would not undergo
effective palladium(II)-catalysed rearrangements due to
binding of the catalyst to the unsaturated side-chains.13,16 We
were interested in exploring the structural requirements of
alkyne derived allylic alcohols that could block catalyst
side-chain binding and perform a Pd(II)-catalysed Overman
rearrangement as part of a more rapid one-pot process leading
to new C-5 substituted aminobicyclo[4.3.0]nonanes. We now
report the synthesis of a series of C-7 substituted hept-2-en-6-
yn-1-ols and the evaluation of these compounds to undergo a
Pd(II)-catalysed Overman rearrangement. As well as using these
allylic alcohols as substrates for a one-pot multistep process
for the diastereoselective preparation of novel aminobicyclo-
[4.3.0]nonanes, we also report further functionalisation of
these products to generate highly substituted sp3-rich, drug-
like polycyclic scaffolds with up to six stereogenic centres.
Results and discussion
To investigate the requirements of alkyne substituents to block
catalyst binding during a Pd(II)-catalysed Overman rearrange-
ment, a series of C-7 substituted hept-2-en-6-yn-1-ols were
prepared in four steps from pent-4-yn-1-ol (4) (Scheme 2).
Sonogashira coupling with various aryl iodides in the presence
of copper(I) iodide (2 mol%) and bis(triphenylphosphine)palla-
dium(II) dichloride (1 mol%) gave disubstituted alkynes 5–7 in
excellent yields.17 An alkyl analogue (9, R = Me) was also pre-
pared by potassium tert-butoxide mediated isomerisation of
hex-5-yn-1-ol (8).18 The various pent-4-yn-1-ols were then sub-
jected to a one-pot Swern oxidation and Horner–Wadsworth–
Emmons reaction under Masamune–Roush conditions which
gave the corresponding (E)-α,β-unsaturated esters 10–14 in
essentially quantitative yields.19,20 Reduction using DIBAL-H
gave the desired hept-2-en-6-yn-1-ols 15–19 in excellent overall
yield.
The ability of hept-2-en-6-yn-1-ols 15–19 to undergo a Pd(II)-
catalysed Overman rearrangement was next investigated. The
study began by exploring the rearrangement of mono-substi-
tuted alkyne, (2E)-hept-2-en-6-yn-1-ol (15) (Table 1, entry 1).
Allylic alcohol 15 was converted to the corresponding allylic tri-
chloroacetimidate using trichloroacetonitrile and a catalytic
amount of DBU.21 Using standard conditions for a Pd(II)-cata-
lysed Overman rearrangement (10 mol% catalyst loading at
rt),22 only small amounts (<10%) of allylic trichloroacetamide
20 could be observed by NMR spectroscopy. A number of reac-
tions were then performed to elucidate the optimal conditions
for the preparation of 20. It was found that addition of a
second batch of catalyst after 24 h and conducting the entire
reaction at 40 °C gave allylic trichloroacetamide 20 in 34%
yield after a reaction time of 48 h. The elevated temperature,
high catalyst loading and long reaction time are exemplary of
Scheme 1 One-pot synthesis of amino substituted bicyclo[4.3.0]
nonanes.
Scheme 2 Synthesis of C-7 substituted hept-2-en-6-yn-1-ols.
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the conditions required for metal catalysed rearrangement of
allylic trichloroacetamides bearing mono-substituted unsatu-
rated side-chains. The rearrangement of disubstituted alkyne
derived allylic trichloroacetamides was next investigated.
While a methyl substituent is relatively small, the use of this
group was sufficient to partially retard catalyst binding and
allow rearrangement using only 10 mol% of catalyst at 20 °C
(entry 2). This gave allylic trichloroacetamide 21 in 55% yield
after 24 h. Using aryl groups with substantially more bulk
proved effective and allowed the efficient synthesis of the
corresponding allylic trichloroacetamides 22–24 in high yields
after a 12 h reaction time (entries 3–5). Interestingly, the yields
were independent of the electronic nature of the aryl groups
indicating that the steric bulk of these substituents is primar-
ily responsible for preventing binding of the catalyst to the
alkyne moiety.
Having identified the structural requirements and optimal
conditions for an efficient Overman rearrangement, these
were incorporated into a one-pot multi-reaction process
including a Ru(II)-catalysed RCEYM step23 and a Diels–Alder
reaction for the preparation of novel aminobicyclo[4.3.0]
nonanes (Scheme 3). Preliminary attempts at the one-pot
preparation of 25 from phenyl substituted allylic alcohol 17
using Grubbs 2nd generation catalyst (7 mol%)24 for the
RCEYM step and N-phenyl maleimide as a dienophile for the
Diels–Alder step, under previously developed conditions for
these reactions14,15 gave low yields of 25 (∼25%). Analysis of
the 1H NMR spectrum of the reaction mixture showed the pres-
ence of the 1,6-enyne 22, indicating that the RCEYM step had
not gone to completion. This was unsurprising as disubsti-
tuted, bulky alkynes often show suppressed reactivity during
RCEYM reactions.23 Methods for improving this step were
investigated. A combination of the use of 1,7-octadiene as an
in situ source of ethylene25 and a higher reaction temperature
(from 75 to 90 °C) resulted in an accelerated RCEYM reaction,
allowing complete conversion of 1,6-enyne 22 to the corres-
ponding cyclopentyl exo-diene. Using these modified con-
ditions as part of the one-pot process gave 5-phenyl
aminobicyclo[4.3.0]nonane 25 as a single diastereomer in 51%
overall yield from allylic alcohol 17 (Scheme 3).26 As previously
reported for the Diels–Alder reaction of trichloroacetamide
Table 1 Palladium(II)-catalysed Overman rearrangement of allylic
alcohols
Entry R Temp (°C) Time (h) Yielda (%)
1b H (15) 40 48 34 (20)
2 Me (16) 20 24 55 (21)
3 Ph (17) 20 12 81 (22)
4 4-NO2C6H4 (18) 20 12 76 (23)
5 4-MeOC6H4 (19) 20 12 83 (24)
a Isolated yields from allylic alcohols 15–19. b A second portion of
catalyst was added after 24 h (20 mol% in total).
Scheme 3 One-pot synthesis of aminobicyclo[4.3.0]nonanes 25–33.
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derived cyclic exo-dienes, the reaction proceeds via a hydrogen
bonding directed endo transition state, generating the syn-pro-
ducts with excellent diastereoselectivity (>20 : 1).14 The relative
stereochemistry of 25 was confirmed by difference NOE experi-
ments, which showed the syn relationship of the hydrogen
atoms at C-3a, C-8, C-8a and C-8b.27 For comparison, use of
the optimised one-pot process was applied to methyl substi-
tuted allylic alcohol 16 which gave 26 in 25% overall yield. The
significantly lower yield for 26 is a consequence of the less
efficient Overman rearrangement for this analogue. Using
phenyl derived allylic alcohol 17, the scope of the one-pot mul-
tistep process was explored using various dienophiles. In all
cases, the compounds were formed as single diastereomers in
good yields over the four steps (40–56%). It should be noted
that the non-symmetrical dienophile, methyl acrylate gave
indane 29 as a single regioisomer. This again is a direct conse-
quence of the hydrogen bonding directed endo transition
state.14
As well as developing a one-pot synthesis of aminobicyclo-
[4.3.0]nonanes using consecutive Pd(II)- and Ru(II)-catalysis,
another major objective of this research programme was to
probe the effect of electron-deficient and electron-rich aryl
substituted alkynes on the outcome of the RCEYM step and
the subsequent one-pot process. While 1,6-enynes bearing
electron-deficient alkyne substituents have been shown to have
a detrimental effect on RCEYM reactions,23a,28 examples with
electron-poor aryl groups have given excellent yields under
forcing conditions.28 Using (2E)-7-(4′-nitrophenyl)hept-2-en-6-
yn-1-ol (18) as a substrate for the one-pot multistep process
and N-phenyl maleimide as the dienophile, gave 4-nitrophenyl
substituted aminobicyclo[4.3.0]nonane 30 as a single diaster-
eomer in 69% yield. In a similar fashion, use of 4-phenyl-1,2,4-
triazole-3,5-dione, tetracyanoethylene or methyl acrylate as
dienophiles for the Diels–Alder step allowed the preparation of
4-nitrophenyl substituted aminobicyclo[4.3.0]nonanes 31–33
in good overall yields. Despite being sterically encumbered
and electron-deficient, the 1,6-enyne produced during these
one-pot processes seems able to undergo a highly effective
RCEYM reaction under our optimal conditions. A more stable
cyclopentyl exo-diene and a cleaner subsequent Diels–Alder
reaction may account for the elevated yields of the 4-nitro-
phenyl series compared to the phenyl-substituted compounds.
Electron-rich allylic alcohol (2E)-7-(4′-methoxyphenyl)hept-
2-en-6-yn-1-ol (19) was then converted to the allylic trichloro-
acetamidate and subjected to the one-pot, three-step process
using N-phenyl maleimide as the dienophile. This gave the
corresponding 4-methoxyphenyl substituted aminobicyclo-
[4.3.0]nonane 34 in only 34% yield. Analysis of the individual
steps of the one-pot process revealed that while the electron-
rich cyclopentyl exo-diene was readily formed during our opti-
mised conditions for the RCEYM reaction, the temperature
(90 °C) of this transformation was resulting in decomposition
of the highly reactive diene. On screening various temperatures
for the RCEYM reaction of electron-rich 1,6-enyne 24, it was
found that the reaction proceeded to completion at a much
lower temperature of 40 °C. Despite application of this
optimised RCEYM step, one-pot reactions using allylic alcohol 19
still gave modest yields of the 4-methoxyphenyl substituted
aminobicyclo[4.3.0]nonane 34. As such, the preparation of this
final series of compounds was conducted as two separate pro-
cesses. Following efficient large-scale preparation of allylic tri-
chloroacetamide 24 (Table 1), this was subjected to a one-pot,
two-step process involving the low temperature RCEYM step
and a Diels–Alder reaction with various electron-deficient dieno-
philes (Scheme 4). This allowed the synthesis of 4-methoxy-
phenyl substituted aminobicyclo[4.3.0]nonanes 34–37 as
single diastereomers in good yields over the two steps.
Having synthesised a novel library of aminobicyclo[4.3.0]
nonanes, a preliminary study was conducted to explore further
functionalisation of these compounds and in particular, the
reactivity of the tetra-substituted alkene moiety. Initially,
hydrogenation of 25 was attempted under standard conditions
(Scheme 5). However, after 48 h, partial reduction of the tri-
chloromethyl group was the only change detected, giving the
dichloroacetamide in 48% yield. Despite the resistance of the
tetra-substituted alkene to undergo hydrogenation, oxidation
of the moiety was readily observed. For example, reaction of 25
with osmium tetroxide in the presence of TMEDA under
Donohoe conditions29 gave dihydroxy derivative 39 as a single
diastereomer in quantitative yield after only 3 h. Based on the
shape of aminobicyclo[4.3.0]nonane 25, it was expected that
reactions of the alkene would take place from the more
exposed convex face of the molecule. This was confirmed by
X-ray crystallography. The (3aS*,5R*,5aR*,8R*,8aR*,8bR*)-
stereoisomer 39 was found to crystallise in the triclinic space
group P1ˉ and the structure clearly shows the syn relationship
Scheme 4 Synthesis of p-methoxyphenyl substituted aminobicyclo-
[4.3.0]nonanes 34–37. aDiels–Alder reaction was done at 111 °C for
5 days.
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of the hydrogen atoms at C-3a, C-8, C-8a and C-8b and the
hydroxyl groups at C-5 and C-5a (Fig. 2).30,31 In a similar
fashion, reaction of 25 with m-CPBA gave epoxide 40 as a
single diastereomer in 65% yield.
Conclusions
In summary, a series of C-7 substituted hept-2-en-6-yn-1-ols
have been examined as substrates for the one-pot diastereo-
selective synthesis of sp3-rich aminobicyclo[4.3.0]nonanes. The
presence of the C-7 groups allowed an effective Pd(II)-catalysed
Overman rearrangement to proceed. Incorporation of this
transformation into a one-pot, three-step process involving a
Ru(II)-catalysed RCEYM reaction and a hydrogen bonding
directed Diels–Alder reaction gave a range of aminobicyclo-
[4.3.0]nonanes in good overall yields. The effect of the elec-
tronic nature of the aryl substituent on the RCEYM step was
also studied and while an electron-poor analogue could be
used as a substrate for the one-pot process using forcing con-
ditions for the RCEYM step, the electron-rich cyclopentyl exo-
diene was found to undergo decomposition during the multi-
step process. Nevertheless, a series of 4-methoxyphenyl
substituted aminobicyclo[4.3.0]nonanes could be prepared
efficiently using a one-pot, two-step process from the allylic tri-
chloroacetamide. The reactivity of these novel compounds was
also explored and aminobicyclo[4.3.0]nonane 25 was readily
oxidised, generating dihydroxy and epoxide derivatives as
single diastereomers in high yields. The combination of the
one-pot, three-step multireaction process with the oxidations
allowed the rapid preparation of these sp3-rich, drug-like poly-
cyclic scaffolds with six stereogenic centres. With the develop-
ment of an effective one-pot synthesis of these compounds
using a Pd(II)-catalysed rearrangement, work is currently
underway to incorporate chiral Pd(II)-catalysts for their asym-
metric synthesis and preparation of natural product targets.
Experimental
All reagents and starting materials were obtained from com-
mercial sources and used as received. All dry solvents were pur-
ified using a PureSolv 500 MD solvent purification system. All
reactions were performed under an atmosphere of argon
unless otherwise mentioned. Flash column chromatography
was performed using Fisher matrix silica 60. Macherey-Nagel
aluminium-backed plates pre-coated with silica gel 60 (UV254)
were used for thin layer chromatography and were visualised
by staining with KMnO4.
1H NMR and 13C NMR spectra were
recorded on a Bruker DPX 400 spectrometer with chemical
shift values in ppm relative to TMS (δH 0.00 and δC 0.0) or
residual chloroform (δH 7.26 and δC 77.2) as standard. Proton
and carbon assignments are based on two-dimensional COSY
and DEPT experiments, respectively. Mass spectra were
obtained using a JEOL JMS-700 spectrometer for EI and CI or a
Bruker Microtof-q for ESI. Infrared spectra were obtained
neat using a Shimadzu IRPrestige-21 spectrometer. Melting
points were determined on a Reichert platform melting point
apparatus.
5-Phenylpent-4-yn-1-ol (5)32
Bis(triphenylphosphine)palladium(II) dichloride (0.022 g,
0.031 mmol) and copper iodide (0.012 g, 0.062 mmol) were
dissolved in triethylamine (43 mL) and iodobenzene (0.42 mL,
3.71 mmol) was added and stirred at room temperature for
0.1 h. Pent-4-yn-1-ol (4) (0.26 g, 3.09 mmol) was added and the
reaction mixture was stirred at room temperature for 48 h. The
reaction mixture was concentrated in vacuo. Purification of the
resulting residue by flash column chromatography (petroleum
Scheme 5 Functionalisation of aminobicyclo[4.3.0]nonane 25.
Fig. 2 View showing the structure of one of the crystallographically
independent molecules of 39. Atomic displacement ellipsoids are drawn
at 50% probability level.
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ether/ethyl acetate, 3 : 1) gave 5-phenylpent-4-yn-1-ol (5)
(0.48 g, 95%) as a colourless oil. Spectroscopic data was
consistent with the literature.32 δH (400 MHz, CDCl3) 1.59
(1H, br s, OH), 1.86 (2H, quin, J 6.5 Hz, 2-H2), 2.54 (2H, t,
J 6.5 Hz, 3-H2), 3.82 (2H, t, J 6.5 Hz, 1-H2), 7.24–7.30 (3H, m,
3 × ArH), 7.36–7.42 (2H, m, 2 × ArH); δC (101 MHz, CDCl3)
16.0 (CH2), 31.4 (CH2), 61.7 (CH2), 81.1 (C), 89.4 (C), 123.8 (C),
127.7 (CH), 128.2 (2 × CH), 131.6 (2 × CH); m/z (CI) 161
(MH+. 100%), 133 (20), 117 (28), 113 (13), 85 (28), 69 (39).
5-(4′-Nitrophenyl)pent-4-yn-1-ol (6)33
5-(4′-Nitrophenyl)pent-4-yn-1-ol (6) was synthesised as
described for 5-phenylpent-4-yn-1-ol (5) using pent-4-yn-1-ol
(4) (0.26 g, 3.09 mmol) and 4-iodo-1-nitrobenzene (0.92 g,
3.71 mmol). Purification by flash column chromatography
(petroleum ether/ethyl acetate, 3 : 1) gave 5-(4′-nitrophenyl)
pent-4-yn-1-ol (6) (0.63 g, 99%) as an orange solid. Mp
30–32 °C; spectroscopic data was consistent with the litera-
ture.33 δH (500 MHz, CDCl3) 1.44 (1H, br t, J 6.8 Hz, OH), 1.89
(2H, quin, J 6.8 Hz, 2-H2), 2.59 (2H, t, J 6.8 Hz, 3-H2), 3.82 (2H,
q, J 6.8 Hz, 1-H2), 7.49–7.54 (2H, m, 2′-H and 6′-H), 8.13–8.18
(2H, m, 3′-H and 5′-H); δC (126 MHz, CDCl3) 16.1 (CH2),
31.1 (CH2), 61.3 (CH2), 79.5 (C), 95.9 (C), 123.4 (2 × CH), 130.9 (C),
132.2 (2 × CH), 146.5 (C); m/z (ESI) 228 (MNa+. 100%), 199 (11),
176 (14), 166 (15), 152 (37), 144 (22), 138 (16), 102 (15).
5-(4′-Methoxyphenyl)pent-4-yn-1-ol (7)34
5-(4′-Methoxyphenyl)pent-4-yn-1-ol (7) was synthesised as
described for 5-phenylpent-4-yn-1-ol (5) using pent-4-yn-1-ol
(4) (0.26 g, 3.09 mmol) and 4-iodoanisole (0.87 g, 3.71 mmol).
Purification by flash column chromatography (petroleum
ether/ethyl acetate, 1 : 1) gave 5-(4′-methoxyphenyl)pent-4-yn-1-
ol (7) (0.58 g, 95%) as a colourless oil. Spectroscopic data was
consistent with the literature.34 δH (400 MHz, CDCl3) 1.54 (1H,
br t, J 6.8 Hz, OH), 1.85 (2H, quin, J 6.8 Hz, 2-H2), 2.52 (2H, t,
J 6.8 Hz, 3-H2), 3.80 (3H, s, OCH3), 3.82 (2H, q, J 6.8 Hz, 1-H2),
6.78–6.84 (2H, m, 3′-H and 5′-H), 7.30–7.35 (2H, m, 2′-H and
6′-H); δC (126 MHz, CDCl3) 15.9 (CH2), 31.5 (CH2), 55.2 (CH3),
61.4 (CH2), 80.8 (C), 87.9 (C), 113.9 (2 × CH), 116.0 (C), 132.9
(2 × CH), 159.1 (C); m/z (EI) 190 (M+. 100%), 159 (24), 145 (75),
134 (55), 115 (38), 83 (59), 75 (23), 47 (16).
Hex-4-yne-1-ol (9)18
To a solution of hex-5-yn-1-ol (8) (0.20 g, 2.04 mmol) in
dimethyl sulfoxide (7 mL) was added potassium tert-butoxide
(0.46 g, 4.08 mmol). The reaction mixture was stirred at room
temperature for 3 h. The reaction was quenched by the
addition of 2 M hydrochloric acid and then extracted with
diethyl ether (4 × 25 mL). The organic layers were combined,
dried (MgSO4), filtered and concentrated in vacuo. Flash
column chromatography (petroleum ether/ethyl acetate, 8 : 2)
gave hex-4-yne-1-ol (9) (0.19 g, 92%) as a yellow oil. Spectro-
scopic data was consistent with the literature.18 δH (400 MHz,
CDCl3) 1.56 (1H, br s, OH), 1.73 (2H, quin, J 6.2 Hz, 2-H2), 1.78
(3H, t, J 2.6 Hz, 6-H3), 2.22–2.29 (2H, m, 3-H2), 3.75 (2H, t,
J 6.2 Hz, 1-H2); δC (126 MHz, CDCl3) 3.4 (CH3), 15.3 (CH2),
31.5 (CH2), 61.7 (CH2), 76.1 (C), 78.5 (C); m/z (CI) 99 (MH
+.
100%), 81 (10), 73 (15), 71 (8), 69 (7).
Ethyl (2E)-hept-2-en-6-ynoate (10)35
Dimethyl sulfoxide (3.16 mL, 44.5 mmol) was added to a
stirred solution of oxalyl chloride (2.11 mL, 25.0 mmol) in
dichloromethane (90 mL) at −78 °C. The mixture was stirred
for 0.3 h before pent-4-yn-1-ol (4) (1.50 g, 17.8 mmol) in
dichloromethane (20 mL) was slowly added. The mixture was
stirred for a further 0.3 h before triethylamine (12.5 mL,
89.0 mmol) was added. This reaction mixture was stirred for
0.5 h at −78 °C and then allowed to warm to room temperature
and stirred for a further 3 h. A solution of lithium chloride
(1.36 g, 32.0 mmol), triethyl phosphonoacetate (6.35 mL,
32.0 mmol) and 1,8-diazabicyclo[5,4,0]undec-7-ene (4.79 mL,
32.0 mmol) in acetonitrile (60 mL) was then prepared and
stirred for 1 h. The Swern solution was concentrated in vacuo,
then the Horner Wadsworth Emmons solution was added and
the reaction mixture was stirred at room temperature over-
night. The reaction was quenched with a saturated solution of
ammonium chloride (45 mL) and concentrated to give an
orange residue, which was then extracted with diethyl ether
(4 × 60 mL). The organic layers were combined, dried (MgSO4),
filtered and concentrated to give an orange oil. Purification by
flash column chromatography (petroleum ether/diethyl ether,
7 : 3) gave ethyl (2E)-hept-2-en-6-ynoate (10) (2.45 g, 91%) as a
yellow oil. Spectroscopic data was consistent with the litera-
ture.35 δH (400 MHz, CDCl3) 1.30 (3H, t, J 7.1 Hz, OCH2CH3),
2.01 (1H, t, J 2.5 Hz, 7-H), 2.34–2.39 (2H, m, 5-H2), 2.41–2.48
(2H, m, 4-H2), 4.20 (2H, q, J 7.1 Hz, OCH2CH3), 5.90 (1H, dt,
J 15.7, 1.5 Hz, 2-H), 6.97 (1H, dt, J 15.7, 6.7 Hz, 3-H);
δC (126 MHz, CDCl3) 14.3 (CH3), 17.4 (CH2), 31.0 (CH2), 60.3
(CH2), 69.4 (CH), 82.7 (C), 122.6 (CH), 146.3 (CH), 166.4 (C);
m/z (CI) 153 (MH+. 100%), 139 (5), 113 (10), 97 (5), 81 (15),
69 (15).
Ethyl (2E)-oct-2-en-6-ynoate (11)
Ethyl (2E)-oct-2-en-6-ynoate (11) was synthesised as described
for ethyl (2E)-hept-2-en-6-ynoate (10) using hex-4-yne-1-ol (9)
(0.17 g, 1.68 mmol). Purification by flash column chromato-
graphy (petroleum ether/diethyl ether, 8 : 2) gave ethyl (2E)-oct-
2-en-6-ynoate (11) (0.27 g, 95%) as a colourless oil. νmax/cm
−1
(neat) 2921 (CH), 1721 (CvO), 1657, 1368, 1265, 1157, 1039,
975; δH (400 MHz, CDCl3) 1.29 (3H, t, J 7.1 Hz, OCH2CH3), 1.77
(3H, t, J 2.3, 8-H3), 2.25–2.32 (2H, m, 5-H2), 2.34–2.41 (2H, m,
4-H2), 4.19 (2H, q, J 7.1 Hz, OCH2CH3), 5.87 (1H, dt, J 15.7,
1.5 Hz, 2-H), 6.98 (1H, dt, J 15.7, 6.6 Hz, 3-H); δC (126 MHz,
CDCl3) 3.4 (CH3), 14.2 (CH3), 17.7 (CH2), 31.6 (CH2), 60.2
(CH2), 76.6 (C), 77.5 (C), 122.1 (CH), 147.1 (CH), 166.5 (C); m/z
(ESI) 189.0883 (MNa+. C10H14NaO2 requires 189.0886).
Ethyl (2E)-7-phenylhept-2-en-6-ynoate (12)36
Ethyl (2E)-7-phenylhept-2-en-6-ynoate (12) was synthesised as
described for ethyl (2E)-hept-2-en-6-ynoate (10) using 5-phenyl-
pent-4-yn-1-ol (5) (0.64 g, 3.96 mmol). Purification by flash
column chromatography (petroleum ether/diethyl ether, 17 : 3)
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gave ethyl (2E)-7-phenylhept-2-en-6-ynoate (12) (0.86 g, 95%) as
a yellow oil. Spectroscopic data was consistent with the litera-
ture.36 δH (400 MHz, CDCl3) 1.30 (3H, t, J 7.1 Hz, OCH2CH3),
2.47–2.61 (4H, m, 4-H2 and 5-H2), 4.20 (2H, q, J 7.1 Hz,
OCH2CH3), 5.93 (1H, dt, J 15.7, 1.5 Hz, 2-H), 7.04 (1H, dt,
J 15.7, 6.6 Hz, 3-H), 7.26–7.31 (3H, m, 3 × ArH), 7.36–7.41
(2H, m, 2 × ArH); δC (101 MHz, CDCl3) 14.3 (CH3), 18.4 (CH2),
31.4 (CH2), 60.2 (CH2), 81.7 (C), 88.3 (C), 122.5 (CH), 123.6 (C),
127.8 (CH), 128.2 (2 × CH), 131.6 (2 × CH), 146.6 (CH),
166.3 (C); m/z (CI) 229 (MH+. 100%), 155 (7), 113 (13), 81 (25),
69 (34).
Ethyl (2E)-7-(4′-nitrophenyl)hept-2-en-6-ynoate (13)
Ethyl (2E)-7-(4′-nitrophenyl)hept-2-en-6-ynoate (13) was syn-
thesised as described for ethyl (2E)-hept-2-en-6-ynoate (10)
using 5-(4′-nitrophenyl)pent-4-yn-1-ol (6) (0.46 g, 2.24 mmol).
Purification by flash column chromatography (petroleum
ether/diethyl ether, 8 : 2) gave ethyl (2E)-7-(4′-nitrophenyl)hept-
2-en-6-ynoate (13) (0.86 g, 95%) as a yellow solid. Mp 56–58 °C;
νmax/cm
−1 (neat) 2960 (CH), 1714 (CvO), 1591 (CvC), 1509,
1340, 1154, 854, 750; δH (400 MHz, CDCl3) 1.30 (3H, t, J 7.1 Hz,
OCH2CH3), 2.50–2.57 (2H, m, 4-H2), 2.60–2.66 (2H, m, 5-H2),
4.21 (2H, q, J 7.1 Hz, OCH2CH3), 5.94 (1H, dt, J 15.7, 1.5 Hz,
2-H), 7.02 (1H, dt, J 15.7, 6.7 Hz, 3-H), 7.49–7.54 (2H, m, 2′-H
and 6′-H), 8.14–8.18 (2H, m, 3′-H and 5′-H); δC (101 MHz,
CDCl3) 14.3 (CH3), 18.6 (CH2), 30.9 (CH2), 60.4 (CH2), 80.3 (C),
94.3 (C), 122.8 (CH), 123.5 (2 × CH), 130.6 (C), 132.3 (2 × CH),
146.0 (CH), 146.8 (C), 166.3 (C); m/z (ESI) 296.0881 (MNa+.
C15H15NNaO4 requires 296.0893).
Ethyl (2E)-7-(4′-methoxyphenyl)hept-2-en-6-ynoate (14)36
Ethyl (2E)-7-(4′-methoxyphenyl)hept-2-en-6-ynoate (14) was
synthesised as described for ethyl (2E)-hept-2-en-6-ynoate (10)
using 5-(4′-methoxyphenyl)pent-4-yn-1-ol (7) (0.55 g, 2.89 mmol).
Purification by flash column chromatography (petroleum
ether/diethyl ether, 8 : 2) gave ethyl (2E)-7-(4′-methoxyphenyl)
hept-2-en-6-ynoate (14) (0.70 g, 94%) as a yellow oil. Spectro-
scopic data was consistent with the literature.36 δH (400 MHz,
CDCl3) 1.29 (3H, t, J 7.1 Hz, OCH2CH3), 2.46–2.59 (4H, m,
4-H2and 5-H2), 3.80 (3H, s, OCH3), 4.20 (2H, q, J 7.1 Hz,
OCH2CH3), 5.92 (1H, dt, J 15.7, 1.5 Hz, 2-H), 6.79–6.84 (2H, m,
3′-H and 5′-H), 7.03 (1H, dt, J 15.7, 6.5 Hz, 3-H), 7.30–7.35
(2H, m, 2′-H and 6′-H); δC (126 MHz, CDCl3) 14.3 (CH3),
18.4 (CH2), 31.5 (CH2), 55.2 (CH3), 60.3 (CH2), 81.4 (C),
86.7 (C), 113.8 (2 × CH), 115.7 (C), 122.4 (CH), 132.9 (2 × CH),
146.8 (CH), 159.2 (C), 166.4 (C); m/z (EI) 258 (M+. 22%),
230 (20), 185 (27), 145 (100), 130 (6), 102 (13), 83 (11).
(2E)-Hept-2-en-6-yn-1-ol (15)37
Ethyl (2E)-hept-2-en-6-ynoate (10) (2.28 g, 15.0 mmol) was dis-
solved in diethyl ether (80 mL) and cooled to −78 °C. DIBAL-H
(1 M in hexane) (33.0 mL, 33.0 mmol) was added dropwise and
the reaction mixture was stirred at −78 °C for 3 h, before
warming to room temperature overnight. The solution was
cooled to 0 °C and quenched by the addition of a saturated
solution of Rochelle salt (50 mL) and warmed to room
temperature with vigorous stirring for 1 h, producing a white
precipitate that was filtered through a pad of Celite® and
washed with diethyl ether (3 × 75 mL). The filtrate was then
dried (MgSO4), filtered and concentrated in vacuo. Purification
by flash column chromatography (petroleum ether/diethyl
ether, 1 : 1) gave (2E)-hept-2-en-6-yn-1-ol (15) (1.44 g, 87%) as a
pale yellow oil. Spectroscopic data was consistent with the lit-
erature.37 δH (500 MHz, CDCl3) 1.42 (1H, br s, OH), 1.99 (1H, t,
J 2.5 Hz, 7-H), 2.28–2.33 (4H, m, 4-H2 and 5-H2), 4.14 (2H, d,
J 4.0 Hz, 1-H2), 5.70–5.81 (2H, m, 2-H and 3-H); δC (126 MHz,
CDCl3) 18.5 (CH2), 31.1 (CH2), 63.5 (CH2), 68.8 (CH), 83.7 (C),
130.5 (CH), 130.6 (CH); m/z (CI) 111 (MH+. 3%), 107 (15),
93 (100), 81 (10), 69 (10).
(2E)-Oct-2-en-6-yn-1-ol (16)
(2E)-Oct-2-en-6-yn-1-ol (16) was synthesised as described for
(2E)-hept-2-en-6-yn-1-ol (15) using ethyl (2E)-oct-2-en-6-ynoate
(11) (0.56 g, 3.36 mmol). Purification by flash column chrom-
atography (petroleum ether/diethyl ether, 1 : 1) gave (2E)-oct-2-
en-6-yn-1-ol (16) (0.36 g, 87%) as a colourless oil. νmax/cm
−1
(neat) 3337 (OH), 2919 (CH), 1436, 1082, 1000, 968; δH
(500 MHz, CDCl3) 1.24–1.29 (1H, m, OH), 1.78 (3H, t, J 2.4 Hz,
8-H3), 2.18–2.27 (4H, m, 4-H2 and 5-H2), 4.11 (2H, t, J 5.3 Hz,
1-H2), 5.66–5.79 (2H, m, 2-H and 3-H); δC (126 MHz, CDCl3) 3.4
(CH3), 18.8 (CH2), 31.7 (CH2), 63.5 (CH2), 76.0 (C), 78.5 (C),
130.1 (CH), 131.3 (CH); m/z (ESI) 147.0782 (MNa+. C8H12NaO
requires 147.0780), 135 (13%), 91 (22).
(2E)-7-Phenylhept-2-en-6-yn-1-ol (17)15
(2E)-7-Phenylhept-2-en-6-yn-1-ol (17) was synthesised as
described for (2E)-hept-2-en-6-yn-1-ol (15) using ethyl (2E)-7-
phenylhept-2-en-6-ynoate (12) (0.67 g, 3.00 mmol). Purification
by flash column chromatography (petroleum ether/ethyl
acetate, 13 : 7) gave (2E)-7-phenylhept-2-en-6-yn-1-ol (17)
(0.54 g, 98%) as a colourless oil. Spectroscopic data was con-
sistent with the literature.15 δH (400 MHz, CDCl3) 1.29 (1H,
br s, OH), 2.33–2.40 (2H, m, 4-H2), 2.50 (2H, t, J 6.8 Hz, 5-H2),
4.13 (2H, br s, 1-H2), 5.72–5.87 (2H, m, 2-H and 3-H), 7.25–7.32
(3H, m, 3 × ArH), 7.36–7.42 (2H, m, 2 × ArH); δC (101 MHz,
CDCl3) 19.5 (CH2), 31.5 (CH2), 63.5 (CH2), 81.2 (C), 89.4 (C),
123.9 (C), 127.7 (CH), 128.2 (2 × CH), 130.5 (CH), 130.9 (CH),
131.6 (2 × CH); m/z (EI) 186 (M+. 13%), 167 (12), 155 (11),
142 (16), 128 (9), 115 (100), 105 (10), 84 (14).
(2E)-7-(4′-Nitrophenyl)hept-2-en-6-yn-1-ol (18)
(2E)-7-(4′-Nitrophenyl)hept-2-en-6-yn-1-ol (18) was synthesised
as described for (2E)-hept-2-en-6-yn-1-ol (15) using ethyl (2E)-7-
(4′-nitrophenyl)hept-2-en-6-ynoate (13) (0.67 g, 2.45 mmol).
Purification by flash column chromatography (petroleum
ether/diethyl ether, 6 : 4) gave (2E)-7-(4′-nitrophenyl)hept-2-en-
6-yn-1-ol (18) (0.47 g, 83%) as a dark green solid. Mp 64–66 °C;
νmax/cm
−1 (neat) 3374 (OH), 2924 (CH), 1593 (CvC), 1516,
1341, 855, 750; δH (400 MHz, CDCl3) 1.35 (1H, br s, OH),
2.35–2.42 (2H, m, 4-H2), 2.54 (2H, t, J 7.1 Hz, 5-H2), 4.14 (2H,
d, J 3.2 Hz, 1-H2), 5.72–5.85 (2H, m, 2-H and 3-H), 7.49–7.54
(2H, m, 2′-H and 6′-H), 8.13–8.18 (2H, m, 3′-H and 5′-H);
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δC (101 MHz, CDCl3) 19.6 (CH2), 31.1 (CH2), 63.5 (CH2),
79.8 (C), 95.6 (C), 123.5 (2 × CH), 130.4 (CH), 130.8 (CH),
130.9 (C), 132.3 (2 × CH), 146.7 (C); m/z (ESI) 254.0784 (MNa+.
C13H13NNaO3 requires 254.0788), 227 (9%), 199 (9).
(2E)-7-(4′-Methoxyphenyl)hept-2-en-6-yn-1-ol (19)
(2E)-7-(4-Methoxyphenyl)hept-2-en-6-yn-1-ol (19) was syn-
thesised as described for (2E)-hept-2-en-6-yn-1-ol (15) using
ethyl (2E)-7-(4′-methoxyphenyl)hept-2-en-6-ynoate (14) (0.44 g,
1.68 mmol). Purification by flash column chromatography
(petroleum ether/diethyl ether, 1 : 1) gave (2E)-7-(4′-methoxy-
phenyl)hept-2-en-6-yn-1-ol (19) (0.34 g, 94%) as a yellow oil.
νmax/cm
−1 (neat) 3368 (OH), 2916 (CH), 1607 (CvC), 1508,
1244, 831; δH (400 MHz, CDCl3) 1.43 (1H, br s, OH), 2.30–2.41
(2H, m, 4-H2), 2.47 (2H, t, J 7.1 Hz, 5-H2), 3.79 (3H, s, OCH3),
4.12 (2H, d, J 4.5 Hz, 1-H2), 5.69–5.85 (2H, m, 2-H and 3-H),
6.78–6.83 (2H, m, 3′-H and 5′-H), 7.29–7.34 (2H, m, 2′-H and
6′-H); δC (101 MHz, CDCl3) 19.5 (CH2), 31.6 (CH2), 55.2 (CH3),
63.2 (CH2), 80.9 (C), 87.9 (C), 113.9 (2 × CH), 116.0 (C), 130.4
(CH), 130.7 (CH), 132.9 (2 × CH), 159.1 (C); m/z (EI) 216.1153
(M+. C14H16O2 requires 216.1150), 172 (17), 145 (100), 130 (7),
102 (15).
3-(2′,2′,2′-Trichloromethylcarbonylamino)hept-1-en-6-yne (20)15
(2E)-Hept-2-en-6-yn-1-ol (15) (0.11 g, 1.00 mmol) was dissolved
in dichloromethane (20 mL) and cooled to 0 °C. To the solu-
tion was added 1,8-diazabicyclo[5.4.0]undec-7-ene (0.03 mL,
0.20 mmol) and trichloroacetonitrile (0.15 mL, 1.50 mmol).
The reaction mixture was allowed to warm to room tempera-
ture before stirring for 3 h. The reaction mixture was filtered
through a short pad of silica gel and the filtrate concentrated
in vacuo to give the allylic trichloroacetimidate, which was
used without further purification. The allylic trichloro-
acetimidate was dissolved in toluene (21 mL) under an argon
atmosphere. Bis(acetonitrile)palladium chloride (0.026 g,
0.10 mmol) was then added to the solution and the reaction
mixture was stirred at 40 °C for 24 h. To the reaction mixture,
an additional portion of bis(acetonitrile)palladium chloride
(0.026 g, 0.10 mmol) was added and the reaction was stirred at
40 °C for 24 h and the solvent was evaporated. Flash column
chromatography using silica (petroleum ether/diethyl ether
10 : 1) gave 3-(2′,2′,2′-trichloromethylcarbonylamino)hept-1-en-
6-yne (20) (0.086 g, 34%) as a white solid. Mp 35–37 °C;
spectroscopic data was consistent with the literature.15
δH (500 MHz, CDCl3) 1.84–2.00 (2H, m, 4-H2), 2.05 (1H, t,
J 2.7 Hz, 7-H), 2.26–2.39 (2H, m, 5-H2), 4.56–4.63 (1H, m, 3-H),
5.27 (1H, d, J 10.5 Hz, 1-HH), 5.30 (1H, d, J 17.2 Hz, 1-HH),
5.82 (1H, ddd, J 17.2, 10.5, 5.6 Hz, 2-H), 6.93 (1H, br s, NH);
δC (126 MHz, CDCl3) 14.8 (CH2), 32.5 (CH2), 53.0 (CH),
69.9 (CH), 83.1 (C), 92.7 (C), 116.9 (CH2), 135.4 (CH), 161.3 (C);
m/z (CI) 254 (MH+. 72%), 220 (55), 186 (42), 184 (37), 132 (12),
89 (100), 69 (27).
3-(2′,2′,2′-Trichloromethylcarbonylamino)oct-1-en-6-yne (21)
3-(2′,2′,2′-Trichloromethylcarbonylamino)oct-1-en-6-yne (21)
was synthesised as described for compound 20, except using
(2E)-oct-2-en-6-yn-1-ol (16) (0.04 g, 0.34 mmol) and a single
portion of bis(acetonitrile)palladium chloride (0.009 g,
0.034 mmol). The reaction was performed at 20 °C for 24 h.
Purification by flash column chromatography (petroleum
ether/diethyl ether, 7 : 3) gave 3-(2′,2′,2′-trichloromethyl-
carbonylamino)oct-1-en-6-yne (21) (0.050 g, 55%) as a colour-
less oil. νmax/cm
−1 (neat) 3331 (NH), 2920 (CH), 1694 (CvO),
1516 (CvC), 1441, 1250, 926, 822; δH (400 MHz, CDCl3)
1.73–1.95 (5H, m, 4-H2 and 8-H3), 2.20–2.30 (2H, m, 5-H2),
4.51–4.62 (1H, m, 3-H), 5.19–5.30 (2H, m, 1-H2), 5.79 (1H, ddd,
J 17.2, 10.4, 5.4 Hz, 2-H), 7.14 (1H, d, J 5.4, NH); δC (101 MHz,
CDCl3) 3.7 (CH3), 14.9 (CH2), 32.7 (CH2), 53.2 (CH), 77.3 (C),
78.0 (C), 92.8 (C), 116.4 (CH2), 135.6 (CH), 161.2 (C); m/z (ESI)
289.9865 (MNa+. C10H12
35Cl3NNaO requires 289.9877).
7-Phenyl-3-(2′,2′,2′-trichloromethylcarbonylamino)hept-1-en-
6-yne (22)
7-Phenyl-3-(2′,2′,2′-trichloromethylcarbonylamino)hept-1-en-
6-yne (22) was synthesised as described for compound 20,
except using (2E)-7-phenylhept-2-en-6-yn-1-ol (17) (0.08 g,
0.44 mmol) and a single portion of bis(acetonitrile)palladium
chloride (0.012 g, 0.044 mmol). The reaction was performed at
20 °C for 12 h. Flash column chromatography using silica
(petroleum ether/diethyl ether, 1 : 1) gave 7-phenyl-3-(2′,2′,2′-
trichloromethylcarbonylamino)hept-1-en-6-yne (22) (0.12 g,
81%) as a colourless oil. νmax/cm
−1 (neat) 3304 (NH), 2955
(CH), 2362, 1714 (CvO), 1511, 1265, 1175; δH (400 MHz,
CDCl3) 1.90–2.09 (2H, m, 4-H2), 2.48–2.61 (2H, m, 5-H2),
4.60–4.69 (1H, m, 3-H), 5.27 (1H, d, J 10.4 Hz, 1-HH), 5.32 (1H,
d, J 17.2 Hz, 1-HH), 5.85 (1H, ddd, J 17.2, 10.4, 5.6 Hz, 2-H),
6.98 (1H, d, J 7.4 Hz, NH), 7.26–7.32 (3H, m, 3 × ArH),
7.37–7.44 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 15.9 (CH2),
32.8 (CH2), 53.2 (CH), 82.0 (C), 88.4 (C), 92.7 (C), 116.9 (CH2),
123.4 (C), 128.0 (CH), 128.3 (2 × CH), 131.7 (2 × CH), 135.6 (CH),
161.4 (C); m/z (ESI) 352.0019 (MNa+. C15H14
35Cl3NNaO requires
352.0033).
7-(4″-Nitrophenyl)-3-(2′,2′,2′-trichloromethylcarbonylamino)-
hept-1-en-6-yne (23)
7-(4″-Nitrophenyl)-3-(2′,2′,2′-trichloromethylcarbonylamino)-
hept-1-en-6-yne (23) was synthesised as described for com-
pound 20, except using (2E)-7-(4′-nitrophenyl)hept-2-en-6-yn-1-
ol (18) (0.06 g, 0.26 mmol) and a single portion of bis(aceto-
nitrile)palladium chloride (0.008 g, 0.026 mmol). The reaction
was performed at 20 °C for 12 h. Purification by flash column
chromatography (petroleum ether/ethyl acetate, 8 : 2) gave
7-(4″-nitrophenyl)-3-(2′,2′,2′-trichloromethylcarbonylamino)-
hept-1-en-6-yne (23) (0.07 g, 76%) as a yellow oil. νmax/cm
−1
(neat) 3339 (NH), 2932 (CH), 1697 (CvO), 1514 (CvC), 1341,
1107, 852, 820; δH (400 MHz, CDCl3) 1.93–2.08 (2H, m, 4-H2),
2.50–2.64 (2H, m, 5-H2), 4.58–4.68 (1H, m, 3-H), 5.25–5.36 (2H,
m, 1-H2), 5.85 (1H, ddd, J 17.2, 10.4, 5.7 Hz, 2-H), 6.80 (1H, d,
J 7.9, NH), 7.50–7.55 (2H, m, 2″-H and 6″-H), 8.12–8.17 (2H, m,
3″-H and 5″-H); δC (101 MHz, CDCl3) 16.2 (CH2), 32.7 (CH2),
53.0 (CH), 80.4 (C), 92.7 (C), 94.3 (C), 117.2 (CH2), 123.5
(2 × CH), 130.5 (C), 132.4 (2 × CH), 135.5 (CH), 146.8 (C),
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161.4 (C); m/z (ESI) 396.9873 (MNa+. C15H13
35Cl3N2NaO3
requires 396.9884).
7-(4″-Methoxyphenyl)-3-(2′,2′,2′-trichloromethylcarbonylamino)-
hept-1-en-6-yne (24)
7-(4″-Methoxyphenyl)-3-(2′,2′,2′-trichloromethylcarbonylamino)
hept-1-en-6-yne (24) was synthesised as described for com-
pound 20, except using (2E)-7-(4′-methoxyphenyl)hept-2-en-6-
yn-1-ol (19) (0.11 g, 0.49 mmol) and a single portion of bis
(acetonitrile)palladium chloride (0.014 g, 0.049 mmol). The
reaction was performed at 20 °C for 12 h. Purification by flash
column chromatography (petroleum ether/ethyl acetate, 8 : 2) gave
7-(4″-methoxyphenyl)-3-(2′,2′,2′-trichloromethylcarbonylamino)-
hept-1-en-6-yne (24) (0.15 g, 83%) as a colourless oil. νmax/cm
−1
(neat) 3340 (NH), 2925 (CH), 1697 (CvO), 1509 (CvC),
1246, 1173, 831; δH (400 MHz, CDCl3) 1.89–2.08 (2H, m,
4-H2), 2.45–2.62 (2H, m, 5-H2), 3.80 (3H, s, OCH3), 4.59–4.69
(1H, m, 3-H), 5.24–5.35 (2H, m, 1-H2), 5.85 (1H, ddd, J 17.1,
10.4, 5.5 Hz, 2-H), 6.79–6.84 (2H, m, 3″-H and 5″-H), 7.02
(1H, d, J 8.0 Hz, NH), 7.30–7.36 (2H, m, 2″-H and 6″-H);
δC (126 MHz, CDCl3) 15.8 (CH2), 32.8 (CH2), 53.2 (CH),
55.3 (CH3), 81.9 (C), 86.8 (C), 92.7 (C), 113.9 (2 × CH),
115.4 (C), 116.7 (CH2), 133.0 (2 × CH), 135.6 (CH), 159.3 (C),
161.4 (C); m/z (ESI) 382.0120 (MNa+. C16H16
35Cl3NNaO2
requires 382.0139).
(3aS*,8R*,8aS*,8bR*)-2,5-Diphenyl-3a,4,6,7,8a,8b-hexahydro-
8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (25)15
(2E)-7-Phenylhept-2-en-6-yn-1-ol (17) (0.12 g, 0.64 mmol) was
dissolved in dichloromethane (16 mL) and cooled to 0 °C. To
the solution, 1,8-diazabicyclo[5.4.0]undec-7-ene (0.02 mL,
0.013 mmol) and trichloroacetonitrile (0.10 mL, 0.966 mmol)
were added. The reaction mixture was allowed to warm to
room temperature and stirred for 3 h. The reaction mixture
was filtered through a short pad of silica gel with diethyl ether
(300 mL) and the filtrate concentrated in vacuo to give the
allylic trichloroacetimidate, which was used without further
purification. The allylic trichloroacetimidate was dissolved in
toluene (16 mL) and bis(acetonitrile)palladium chloride
(0.018 g, 0.064 mmol) was then added and the reaction
mixture was stirred at room temperature for 12 h. Grubbs
second generation catalyst (0.04 g, 0.05 mmol) was added with
1,7-octadiene (0.39 mL, 2.58 mmol) and the reaction mixture
was stirred for 18 h at 90 °C. N-Phenyl maleimide (0.17 g,
0.96 mmol) was added with hydroquinone (0.008 g,
0.008 mmol). The reaction mixture was stirred for 18 h at
75 °C. The reaction mixture was then cooled and the solvent
was evaporated. Flash column chromatography (petroleum
ether/diethyl ether, 7 : 3) gave compound 25 (0.17 g, 51%) as a
yellow solid. Mp 151–153 °C; spectroscopic data was consistent
with the literature.15 δH (400 MHz, CDCl3) 1.75 (1H, dq, J 12.3,
10.2 Hz, 7-HH), 2.10–2.20 (1H, m, 7-HH), 2.53–2.66 (3H, m,
4-HH and 6-H2), 3.12 (1H, dd, J 9.1, 5.8 Hz, 8a-H), 3.30 (1H,
dd, J 15.2, 1.4 Hz, 4-HH), 3.46–3.56 (2H, m, 3a-H and 8b-H),
4.88–5.01 (1H, m, 8-H), 7.06–7.10 (2H, m, 2 × ArH), 7.23–7.47
(8H, m, 8 × ArH), 8.96 (1H, d, J 9.6 Hz, NH); δC (126 MHz,
CDCl3) 28.4 (CH2), 29.9 (CH2), 31.6 (CH2), 40.3 (CH), 41.7 (CH),
43.7 (CH), 52.8 (CH), 92.9 (C), 126.5 (2 × CH), 127.2 (CH),
127.5 (2 × CH), 128.5 (2 × CH), 129.2 (CH), 129.4 (2 × CH),
130.3 (C), 131.4 (C), 139.0 (C), 139.6 (C), 162.3 (C), 178.5 (C),
179.7 (C); m/z (ESI) 525 (MNa+. 100%), 481 (18%), 454 (7),
413 (7), 345 (24), 323 (21), 297 (9), 236 (11), 218 (7).
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-methyl-2-
phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]-
isoindole-1,3(2H,3aH)-dione (26)
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-methyl-2-phenyl-
8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (26) was synthesised as described for
compound 25 using (2E)-oct-2-en-6-yn-1-ol (16) (0.05 g,
0.36 mmol). Purification by flash column chromatography
(petroleum ether/diethyl ether, 7 : 3) gave compound 26
(0.04 g, 25%) as a white solid. Mp 126–128 °C; νmax/cm
−1
(neat) 3303 (NH), 2928 (CH), 1696 (CvO), 1518 (CvC), 1389,
1188, 736; δH (400 MHz, CDCl3) 1.69–1.81 (4H, m, 7-HH and
5-CH3), 2.09–2.22 (2H, m, 6-HH and 7-HH), 2.26–2.35 (1H, m,
4-HH), 2.45–2.55 (1H, m, 6-HH), 2.69 (1H, dd, J 14.8, 1.4 Hz,
4-HH), 2.84–2.91 (1H, m, 8a-H), 3.31 (1H, ddd, J 8.6, 7.1,
1.4 Hz, 3a-H), 3.38 (1H, dd, J 8.6, 6.2 Hz, 8b-H), 4.76–4.89 (1H,
m, 8-H), 7.11–7.15 (2H, m, 2 × ArH), 7.38–7.50 (3H, m,
3 × ArH), 8.97 (1H, d, J 9.6 Hz, NH); δC (101 MHz, CDCl3)
19.3 (CH3), 26.1 (CH2), 31.6 (CH2), 31.9 (CH2), 39.9 (CH),
41.4 (CH), 42.5 (CH), 53.1 (CH), 92.9 (C), 126.2 (C), 126.4
(2 × CH), 129.1 (CH), 129.3 (2 × CH), 131.6 (C), 136.3 (C),
162.2 (C), 178.5 (C), 179.9 (C); m/z (ESI) 463.0350 (MNa+.
C20H19
35Cl3N2NaO3 requires 463.0353).
(9R*,9aS*)-2,6-Diphenyl-7,8,9,9a-tetrahydro-9-(2′,2′,2′-
trichloromethylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]-
triazolo[1,2-a]pyridazine-1,3(2H)-dione (27)
(9R*,9aS*)-2,6-Diphenyl-7,8,9,9a-tetrahydro-9-(2′,2′,2′-trichloro-
methylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]triazolo[1,2-a]-
pyridazine-1,3(2H)-dione (27) was synthesised as described for
compound 25 using (2E)-7-phenylhept-2-en-6-yn-1-ol (17)
(0.08 g, 0.40 mmol) and 4-phenyl-1,2,4-triazole-3,5-dione
(0.13 g, 0.72 mmol). Purification by flash column chromato-
graphy (petroleum ether/ethyl acetate, 1 : 1) gave compound 27
(0.08 g, 40%) as a dark yellow solid. Mp 176–178 °C; νmax/cm
−1
(neat) 3405 (NH), 2925 (CH), 1714 (CvO), 1704 (CvO) 1503
(CvC), 1420, 752; δH (400 MHz, CDCl3) 2.14–2.29 (2H, m,
8-H2), 2.44–2.54 (1H, m, 7-HH), 2.60–2.71 (1H, m, 7-HH), 4.40
(1H, ddd, J 16.6, 5.3, 2.3 Hz, 5-HH), 4.54 (1H, ddd, J 16.6, 5.3,
2.9 Hz, 5-HH), 4.57–4.61 (1H, m, 9a-H), 4.90–4.95 (1H, m, 9-H),
6.73 (1H, d, J 6.0 Hz, NH), 7.28–7.56 (10H, m, 10 × ArH);
δC (101 MHz, CDCl3) 24.4 (CH2), 27.8 (CH2), 45.6 (CH2),
52.5 (CH), 59.9 (CH), 92.7 (C), 125.5 (2 × CH), 127.7 (2 × CH),
128.4 (CH), 128.7 (CH), 128.7 (C), 128.9 (2 × CH), 129.2
(2 × CH), 130.9 (C), 132.3 (C), 136.3 (C), 151.7 (C), 152.7 (C),
161.3 (C); m/z (ESI) 527.0395 (MNa+. C23H19
35Cl3N4NaO3
requires 527.0415).
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(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-phenyl-6,6,7,7-tetracyano-
1-(2′,2′,2′-trichloromethylcarbonylamino)indene (28)
(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-phenyl-6,6,7,7-tetracyano-
1-(2′,2′,2′-trichloromethylcarbonylamino)indene (28) was syn-
thesised as described for compound 25 using (2E)-7-phenyl-
hept-2-en-6-yn-1-ol (17) (0.06 g, 0.32 mmol) and
tetracyanoethylene (0.25 g, 1.93 mmol). Purification by flash
column chromatography (petroleum ether/ethyl acetate, 10 : 1)
gave compound 28 (0.08 g, 56%) as a yellow solid. Mp
136–138 °C; νmax/cm
−1 (neat) 3347 (NH), 2927 (CH), 1705
(CvO), 1517 (CvC), 1218, 823, 769; δH (400 MHz, CDCl3)
1.90–2.03 (1H, m, 2-HH), 2.33–2.47 (2H, m, 2-HH and 3-HH),
2.63–2.74 (1H, m, 3-HH), 3.31 (1H, dt, J 16.4, 1.7 Hz, 5-HH),
3.46–3.56 (2H, m, 5-HH and 7a-H), 4.41–4.53 (1H, m, 1-H),
6.92 (1H, J 7.6 Hz, NH), 7.17–7.22 (2H, m, 2 × ArH), 7.35–7.47
(3H, m, 3 × ArH); δC (126 MHz, CDCl3) 26.3 (CH2), 29.0 (CH2),
37.5 (CH2), 39.7 (C), 41.4 (C), 49.7 (CH), 54.9 (CH), 91.8 (C),
108.2 (C), 110.5 (C), 110.8 (C), 110.8 (C), 127.1 (2 × CH),
127.8 (C), 129.0 (CH), 129.2 (2 × CH), 131.4 (C), 136.4 (C),
162.5 (C); m/z (ESI) 480.0133 (MNa+. C21H14
35Cl3N5NaO
requires 480.0156).
Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-phenyl-1-
(2′,2′,2′-trichloromethylcarbonylamino)indene-7-carboxylate (29)
Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-phenyl-1-
(2′,2′,2′-trichloromethylcarbonylamino)indene-7-carboxylate (29)
was synthesised as described for compound 25 using (2E)-7-
phenylhept-2-en-6-yn-1-ol (17) (0.09 g, 0.48 mmol) and methyl
acrylate (0.13 mL, 1.44 mmol). Purification by flash column
chromatography (petroleum ether/diethyl ether, 8 : 2) gave
compound 29 (0.09 g, 46%) as a yellow oil; νmax/cm
−1 (neat)
3414 (NH), 2952 (CH), 1712 (CvO), 1511 (CvC), 1200, 822,
757; δH (500 MHz, CDCl3) 1.65–1.77 (1H, m, 2-HH), 1.95–2.10
(2H, m, 2-HH and 6-HH) 2.22–2.38 (3H, m, 3-HH, 5-HH and
6-HH), 2.40–2.49 (1H, m, 3-HH), 2.50–2.62 (1H, m, 5-HH), 3.00
(1H, q, J 4.5 Hz, 7-H), 3.04–3.12 (1H, m, 7a-H), 3.72 (1H, s,
OCH3), 4.63 (1H, qd, J 8.6, 5.0 Hz, 1-H), 7.16–7.26 (3H, m,
3 × ArH), 7.29–7.36 (2H, m, 2 × ArH), 7.68 (1H, d, J 8.6 Hz,
NH); δC (126 MHz, CDCl3) 26.4 (CH2), 27.8 (CH2), 28.9 (CH2),
31.7 (CH2), 39.5 (CH), 43.9 (CH), 52.1 (CH), 53.2 (CH3),
92.9 (C), 126.6 (CH), 127.6 (2 × CH), 128.1 (2 × CH), 130.0 (C),
136.0 (C), 141.9 (C), 161.7 (C), 175.5 (C); m/z (ESI) 438.0381
(MNa+. C19H20
35Cl3NNaO3 requires 438.0401).
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-(4″-nitrophenyl)-
2-phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]-
isoindole-1,3(2H,3aH)-dione (30)
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-(4″-nitrophenyl)-
2-phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]-
isoindole-1,3(2H,3aH)-dione (30) was synthesised as described
for compound 25 using (2E)-7-(4′-nitrophenyl)hept-2-en-6-yn-
1-ol (18) (0.05 g, 0.20 mmol). Flash column chromatography
(petroleum ether/ethyl acetate, 7 : 3) gave compound 30
(0.08 g, 69%) as a yellow solid. Mp 160–162 °C; νmax/cm
−1
(neat) 3306 (NH), 2956 (CH), 1695 (CvO), 1513 (CvC), 1344,
1191, 821, 753; δH (400 MHz, CDCl3) 1.79 (1H, qd, J 12.4,
8.0 Hz, 7-HH), 2.16–2.26 (1H, m, 7-HH), 2.50–2.70 (3H, m,
4-HH and 6-H2), 3.17 (1H, dd, J 9.5, 6.1 Hz, 8a-H), 3.33 (1H,
dd, J 14.8, 1.0 Hz, 4-HH), 3.53–3.59 (2H, m, 3a-H and 8b-H),
4.90–5.02 (1H, m, 8-H), 7.02–7.08 (2H, m, 2″-H and 6″-H),
7.37–7.49 (5H, m, 5 × ArH), 8.16–8.27 (2H, m, 3″-H and 5″-H),
8.93 (1H, d, J 9.5 Hz, NH); δC (126 MHz, CDCl3) 28.6 (CH2),
31.3 (CH2), 31.7 (CH2), 40.2 (CH), 41.4 (CH), 44.2 (CH), 52.6
(CH), 92.8 (C), 123.8 (2 × CH), 126.4 (2 × CH), 128.2 (2 × CH),
128.9 (C), 129.4 (CH), 129.5 (2 × CH), 131.2 (C), 143.7 (C), 145.4
(C), 146.7 (C), 162.4 (C), 178.3 (C), 179.3 (C); m/z (ESI) 570.0347
(MNa+. C25H20
35Cl3N3NaO5 requires 570.0361).
(9R*,9aS*)-6-(4″-Nitrophenyl)-2-phenyl-7,8,9,9a-tetrahydro-
9-(2′,2′,2′-trichloromethylcarbonylamino)-1H,5H-cyclopent[c]-
[2,4,10]triazolo[1,2-a]pyridazine-1,3(2H)-dione (31)
(9R*,9aS*)-6-(4″-Nitrophenyl)-2-phenyl-7,8,9,9a-tetrahydro-9-
(2′,2′,2′-trichloromethylcarbonylamino)-1H,5H-cyclopent[c]-
[2,4,10]triazolo[1,2-a]pyridazine-1,3(2H)-dione (31) was syn-
thesised as described for compound 25 using (2E)-7-(4′-nitro-
phenyl)hept-2-en-6-yn-1-ol (18) (0.07 g, 0.30 mmol) and
4-phenyl-1,2,4-triazole-3,5-dione (0.06 g, 0.36 mmol). Purifi-
cation by flash column chromatography (petroleum ether/
ethyl acetate, 1 : 1) gave compound 31 (0.11 g, 63%) as a yellow
solid. Mp 160–162 °C; νmax/cm
−1 (neat) 3398 (NH), 2925 (CH),
1711 (CvO), 1515 (CvC), 1420, 1343, 854, 751; δH (400 MHz,
CDCl3) 2.22–2.33 (2H, m, 8-H2), 2.45–2.56 (1H, m, 7-HH),
2.60–2.72 (1H, m, 7-HH), 4.41 (1H, dq, J 16.0, 4.0 Hz, 5-HH),
4.52 (1H, dq, J 16.0, 4.0 Hz, 5-HH), 4.57–4.62 (1H, m, 9a-H),
4.86–4.93 (1H, m, 9-H), 6.77 (1H, d, J 5.8 Hz, NH), 7.33–7.54
(7H, m, 7 × ArH), 8.24–8.31 (2H, m, 3″-H and 5″-H);
δC (101 MHz, CDCl3) 24.9 (CH2), 27.6 (CH2), 45.3 (CH2), 52.6
(CH), 60.4 (CH), 92.6 (C), 124.2 (2 × CH), 125.5 (2 × CH), 126.5
(C), 128.6 (CH), 128.7 (2 × CH), 129.3 (2 × CH), 130.7 (C), 136.0
(C), 142.9 (C), 147.6 (C), 151.8 (C), 152.8 (C), 161.5 (C); m/z
(ESI) 572.0239 (MNa+. C23H18
35Cl3N5NaO5 requires 572.0266).
(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-(4″-nitrophenyl)-6,6,7,7-
tetracyano-1-(2′,2′,2′-trichloromethylcarbonylamino)indene (32)
(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-(4″-nitrophenyl)-6,6,7,7-
tetracyano-1-(2′,2′,2′-trichloromethylcarbonylamino)indene (32)
was synthesised as described for compound 25 using (2E)-7-(4′-
nitrophenyl)hept-2-en-6-yn-1-ol (18) (0.07 g, 0.30 mmol) and
tetracyanoethylene (0.23 g, 1.8 mmol). Purification by flash
column chromatography (petroleum ether/diethyl ether, 6 : 4)
gave compound 32 (0.11 g, 73%) as a yellow solid. Mp
128–130 °C; νmax/cm
−1 (neat) 3334 (NH), 2924 (CH), 1709
(CvO), 1520 (CvC), 1347, 1218, 855, 757; δH (400 MHz,
CDCl3) 1.98–2.09 (1H, m, 2-HH), 2.31–2.46 (2H, m, 2-HH and
3-HH), 2.65–2.74 (1H, m, 3-HH), 3.29–3.37 (1H, m, 5-HH),
3.50–3.58 (2H, m, 5-HH and 7a-H), 4.43–4.52 (1H, m, 1-H),
6.95 (1H, d, J 8.3 Hz, NH), 7.39–7.44 (2H, m, 2″-H and 6″-H),
8.29–8.34 (2H, m, 3″-H and 5″-H); δC (101 MHz, CDCl3)
26.4 (CH2), 28.8 (CH2), 37.0 (CH2), 39.6 (C), 41.3 (C), 49.8 (CH),
54.8 (CH), 91.7 (C), 108.1 (C), 110.2 (C), 110.5 (C), 110.5 (C),
124.5 (2 × CH), 126.0 (C), 128.6 (2 × CH), 134.0 (C),
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142.8 (C), 148.0 (C), 162.7 (C); m/z (ESI) 524.9983 (MNa+.
C21H13
35Cl3N6NaO3 requires 525.0007), 357 (21%), 303 (22),
289 (29), 253 (25), 235 (8).
Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-
(4″-nitrophenyl)-1-(2′,2′,2′-trichloromethylcarbonylamino)-
indene-7-carboxylate (33)
Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-(4″-nitrophenyl)-
1-(2′,2′,2′-trichloromethylcarbonylamino)indene-7-carboxylate
(33) was synthesised as described for compound 25 using (2E)-
7-(4′-nitrophenyl)hept-2-en-6-yn-1-ol (18) (0.07 g, 0.29 mmol)
and methyl acrylate (0.08 mL, 0.87 mmol). Purification by
flash column chromatography (petroleum ether/diethyl ether,
8 : 2) gave compound 33 (0.06 g, 46%) as a colourless oil;
νmax/cm
−1 (neat) 3389 (NH), 2930 (CH), 1710 (CvO), 1514
(CvC), 1344, 821, 752; δH (400 MHz, CDCl3) 1.71–1.84 (1H, m,
2-HH), 1.95–2.15 (2H, m, 2-HH and 3-HH), 2.24–2.61 (5H, m,
3-HH, 5-H2 and 6-H2), 3.04 (1H, q, J 4.2 Hz, 7-H), 3.09–3.15
(1H, m, 7a-H), 3.72 (1H, s, OCH3), 4.66 (1H, qd, J 9.0, 7.2 Hz,
1-H), 7.32–7.38 (2H, m, 2″-H and 6″-H), 7.58 (1H, d, J 9.0 Hz,
NH), 8.16–8.22 (2H, m, 3″-H and 5″-H); δC (101 MHz,
CDCl3) 26.5 (CH2), 27.3 (CH2), 29.4 (CH2), 31.8 (CH2),
39.2 (CH), 44.2 (CH), 52.2 (CH), 52.9 (CH3), 92.7 (C),
123.5 (2 × CH), 127.8 (C), 128.4 (2 × CH), 139.5 (C),
146.4 (C), 148.7 (C), 161.8 (C), 175.5 (C); m/z (EI) 460.0359
(M+. C19H19
35Cl3N2O5 requires 460.0360), 299 (100%), 240 (71),
194 (16), 165 (12), 83 (17).
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-
(4″-methoxyphenyl)-2-phenyl-8-(2′,2′,2′-trichloro-
methylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (34)
7-(4″-Methoxyphenyl)-3-(2′,2′,2′-trichloromethylcarbonylamino)
hept-1-en-6-yne (24) (0.04 g, 0.12 mmol) was dissolved in
toluene (3 mL) and Grubbs second generation catalyst
(0.007 g, 0.008 mmol) was added with 1,7-octadiene (0.07 mL,
0.48 mmol) and the reaction mixture was stirred for 20 h at
40 °C. N-Phenyl maleimide (0.03 g, 0.18 mmol) was added
with hydroquinone (0.003 g, 0.003 mmol). The reaction
mixture was stirred for 24 h at 75 °C. The reaction mixture was
then cooled and the solvent was evaporated. Flash column
chromatography (petroleum ether/diethyl ether, 8 : 2) gave
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-(4″-methoxy-
phenyl)-2-phenyl-8-(2′,2′,2′-trichloromethylcarbonylamino)-
cyclopent[e]isoindole-1,3(2H,3aH)-dione (34) (0.042 g, 65%) as
a yellow solid. Mp 115–117 °C; νmax/cm
−1 (neat) 3308 (NH),
2959 (CH), 1698 (CvO), 1512 (CvC), 1391, 1247, 823;
δH (400 MHz, CDCl3) 1.66–1.81 (1H, m, 7-HH), 2.09–2.19 (1H,
m, 7-HH), 2.52–2.62 (3H, m, 4-HH and 6-H2), 3.10 (1H, dd,
J 8.9, 6.3 Hz, 8a-H), 3.27 (1H, dd, J 15.2, 1.2 Hz, 4-HH),
3.44–3.54 (2H, m, 3a-H and 8b-H), 3.81 (3H, s, OCH3),
4.87–4.99 (1H, m, 8-H), 6.85–6.92 (2H, m, 3″-H and 5″-H),
7.04–7.09 (2H, m, 2 × ArH), 7.17–7.23 (2H, m, 2″-H and 6″-H),
7.34–7.46 (3H, m, 3 × ArH), 8.97 (1H, d, J 9.6 Hz, NH);
δC (101 MHz, CDCl3) 28.3 (CH2), 31.6 (CH2), 31.7 (CH2), 40.3
(CH), 41.7 (CH), 43.7 (CH), 52.9 (CH), 55.3 (CH3), 92.9 (C),
113.8 (2 × CH), 126.5 (2 × CH), 128.7 (2 × CH), 129.1 (CH),
129.4 (2 × CH), 129.8 (C), 131.4 (C), 131.5 (C), 138.1 (C),
158.7 (C), 162.3 (C), 178.6 (C), 179.8 (C); m/z (ESI) 555.0599
(MNa+. C26H23
35Cl3N2NaO4 requires 555.0616).
(9R*,9aS*)-6-(4″-Methoxyphenyl)-2-phenyl-7,8,9,9a-tetrahydro-
9-(2′,2′,2′-trichloromethylcarbonylamino)-1H,5H-cyclopent[c]-
[2,4,10]triazolo[1,2-a]pyridazine-1,3(2H)-dione (35)
(9R*,9aS*)-6-(4″-Methoxyphenyl)-2-phenyl-7,8,9,9a-tetrahydro-
9-(2′,2′,2′-trichloromethylcarbonylamino)-1H,5H-cyclopent[c]-
[2,4,10]triazolo[1,2-a]pyridazine-1,3(2H)-dione (35) was syn-
thesised as described for compound 34 using 7-(4″-methoxy-
phenyl)-3-(2′,2′,2′-trichloromethylcarbonylamino)hept-1-en-6-
yne (24) (0.03 g, 0.09 mmol) and 4-phenyl-1,2,4-triazole-3,5-
dione (0.02 g, 0.11 mmol). The Diels–Alder reaction was stirred
for 24 h at 75 °C. Purification by flash column chromatography
(petroleum ether/ethyl acetate, 6 : 4) gave compound 35
(0.04 g, 76%) as a dark yellow solid. Mp 154–156 °C; νmax/cm
−1
(neat) 3406 (NH), 2932 (CH), 1774 (CvO), 1715 (CvO), 1703
(CvO), 1510 (CvC), 1420, 1250, 821, 734; δH (400 MHz,
CDCl3) 2.12–2.30 (2H, m, 8-H2), 2.44–2.56 (1H, m, 7-HH),
2.61–2.71 (1H, m, 7-HH), 3.85 (3H, s, OCH3), 4.36 (1H, ddd,
J 16.0, 4.8, 2.6 Hz, 5-HH), 4.49–4.61 (2H, m, 5-HH and 9a-H),
4.92 (1H, q, J 5.8 Hz, 9-H), 6.70 (1H, d, J 5.8 Hz, NH), 6.93–6.99
(2H, m, 3″-H and 5″-H), 7.22–7.56 (7H, m, 7 × ArH);
δC (101 MHz, CDCl3) 24.5 (CH2), 27.9 (CH2), 45.5 (CH2), 52.3
(CH), 55.4 (CH3), 59.8 (CH), 92.6 (C), 114.3 (2 × CH), 125.5
(2 × CH), 128.2 (C), 128.4 (CH), 128.4 (C), 128.9 (2 × CH), 129.2
(2 × CH), 130.9 (C), 131.1 (C), 151.7 (C), 152.6 (C), 159.8 (C),
161.2 (C); m/z (ESI) 557.0510 (MNa+. C24H21
35Cl3N4NaO4
requires 557.0521).
(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-(4″-methoxyphenyl)-
6,6,7,7-tetracyano-1-(2′,2′,2′-trichloromethylcarbonylamino)-
indene (36)
(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-(4″-methoxyphenyl)-6,6,7,7-
tetracyano-1-(2′,2′,2′-trichloromethylcarbonylamino)indene
(36) was synthesised as described for compound 34 using 7-
(4″-methoxyphenyl)-3-(2′,2′,2′-trichloromethylcarbonylamino)-
hept-1-en-6-yne (24) (0.04 g, 0.10 mmol) and tetracyanoethyl-
ene (0.08 g, 0.60 mmol). The Diels–Alder reaction was stirred
for 24 h at 75 °C. Purification by flash column chromatography
(petroleum ether/ethyl acetate, 6 : 4) gave compound 36
(0.03 g, 57%) as a yellow solid. Mp 116–118 °C; νmax/cm
−1
(neat) 3370 (NH), 2935 (CH), 1711 (CvO), 1513 (CvC), 1248,
1178, 824; δH (400 MHz, CDCl3) 1.88–2.02 (1H, m, 2-HH),
2.33–2.47 (2H, m, 2-HH and 3-HH), 2.64–2.77 (1H, m, 3-HH),
3.24–3.33 (1H, m, 5-HH), 3.44–3.54 (2H, m, 5-HH and 7a-H),
3.84 (3H, s, OCH3), 4.39–4.51 (1H, m, 1-H), 6.91–6.97 (3H, m,
3″-H, 5″-H and NH), 7.11–7.15 (2H, m, 2″-H and 6″-H);
δC (101 MHz, CDCl3) 26.4 (CH2), 29.1 (CH2), 37.6 (CH2),
39.7 (C), 41.4 (C), 50.0 (CH), 54.9 (CH), 55.4 (CH3), 91.7 (C),
108.2 (C), 110.4 (C), 110.7 (C), 110.8 (C), 114.5 (2 × CH), 127.5
(C), 128.4 (2 × CH), 128.6 (C), 130.5 (C), 159.9 (C), 162.5 (C);
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m/z (ESI) 510.0253 (MNa+. C22H16
35Cl3N5NaO2 requires
510.0262).
Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-
(4″-methoxyphenyl)-1-(2′,2′,2′-trichloromethylcarbonylamino)-
indene-7-carboxylate (37)
Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-(4″-methoxy-
phenyl)-1-(2′,2′,2′-trichloromethylcarbonylamino)indene-7-carb-
oxylate (37) was synthesised as described for compound 34
using 7-(4″-methoxyphenyl)-3-(2′,2′,2′-trichloromethylcarbonyl-
amino)hept-1-en-6-yne (24) (0.04 g, 0.11 mmol) and methyl
acrylate (0.03 mL, 0.33 mmol). The Diels–Alder reaction was
stirred for 5 days at 111 °C. Purification by flash column
chromatography (petroleum ether/diethyl ether, 7 : 3) gave
compound 37 (0.03 g, 59%) as a pale yellow oil; νmax/cm
−1
(neat) 3350 (NH), 2935 (CH), 1712 (CvO), 1608, 1510 (CvC),
1246, 1175, 1035, 822, 737; δH (400 MHz, CDCl3) 1.64–1.76
(1H, m, 2-HH), 1.93–2.08 (2H, m, 2-HH, and 6-HH), 2.21–2.38
(3H, m, 3-HH, 5-HH and 6-HH), 2.40–2.59 (2H, m, 3-HH and
5-HH), 2.99 (1H, q, J 4.6 Hz, 7-H), 3.03–3.11 (1H, m, 7a-H), 3.71
(1H, s, OCH3), 3.81 (1H, s, OCH3), 4.63 (1H, qd, J 9.0, 6.9 Hz,
1-H), 6.84–6.89 (2H, m, 3″-H and 5″-H), 7.10–7.16 (2H, m, 2″-H
and 6″-H), 7.68 (1H, d, J 9.0 Hz, NH); δC (101 MHz, CDCl3)
26.4 (CH2), 27.8 (CH2), 29.0 (CH2), 31.6 (CH2), 39.5 (CH), 43.9
(CH), 52.1 (CH), 53.2 (CH3), 55.3 (CH3), 92.9 (C), 113.4
(2 × CH), 128.7 (2 × CH), 129.4 (C), 134.3 (C), 135.1 (C),
158.3 (C), 161.7 (C), 175.5 (C); m/z (ESI) 468.0486 (MNa+.
C20H22
35Cl3NNaO4 requires 468.0507).
(3aS*,8R*,8aS*,8bR*)-2,5-Diphenyl-3a,4,6,7,8a,8b-hexahydro-
8-(2′,2′-dichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (38)
To a solution of (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-
hexahydro-8-(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]iso-
indole-1,3(2H,3aH)-dione (25) (0.08 g, 0.16 mmol) in ethyl
acetate (4 mL) was added 10% palladium on charcoal (0.02 g).
The mixture was stirred under an atmosphere of hydrogen at
room temperature for 48 h. The reaction mixture was filtered
through a short pad of Celite® with diethyl ether (80 mL) and
the solvent was evaporated. Purification by flash column
chromatography (petroleum ether/ethyl acetate, 7 : 3) gave
compound 38 (0.04 g, 48%) as a white solid. Mp 138–140 °C;
νmax/cm
−1 (neat) 3323 (NH), 2922 (CH), 1690 (CO), 1524
(CvC), 1497, 1389, 1196, 808, 734; δH (400 MHz, CDCl3)
1.66–1.80 (1H, m, 7-HH), 2.05–2.15 (1H, m, 7-HH), 2.52–2.64
(3H, m, 4-HH and 6-H2), 3.07 (1H, dd, J 8.7, 6.4 Hz, 8a-H), 3.29
(1H, dd, J 15.3, 2.9 Hz, 4-HH), 3.44–3.54 (2H, m, 3a-H and 8b-
H), 4.89–5.01 (1H, m, 8-H), 5.99 (1H, s, CHCl2), 7.06–7.12 (2H,
m, 2 × ArH), 7.22–7.53 (8H, m, 8 × ArH), 8.66 (1H, d, J 9.7 Hz,
NH); δC (126 MHz, CDCl3) 28.4 (CH2), 31.7 (2 × CH2), 40.3
(CH), 41.7 (CH), 43.7 (CH), 51.6 (CH), 66.7 (CH), 126.6
(2 × CH), 127.2 (CH), 127.5 (2 × CH), 128.4 (2 × CH), 129.1
(CH), 129.4 (2 × CH), 130.1 (C), 131.5 (C), 139.0 (C), 139.9 (C),
164.6 (C), 178.6 (C), 179.7 (C); m/z (EI) 468.1012
(M+. C25H22
35Cl2N2O3 requires 468.1007), 341 (100%), 194 (71),
167 (34), 152 (11), 77 (11).
(3aS*,5R*,5aR*,8R*,8aR*,8bR*)-5,5a-Dihydroxy-2,5-
diphenyl-3a,4,5,5a,6,7,8a,8b-octahydro-8-(2′,2′,2′-
trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (39)
(3aS*,8R*,8aS*,8bR*)-2,5-Diphenyl-3a,4,6,7,8a,8b-hexahydro-8-
(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (25) (0.04 g, 0.08 mmol) was dissolved in
dichloromethane (2 mL) at −78 °C. Tetramethyl-
ethylenediamine (0.013 mL, 0.09 mmol) was added and the
reaction mixture stirred for 0.1 h, before the addition of
osmium tetroxide (0.02 g, 0.09 mmol). The dark coloured solu-
tion was stirred for 1 h at −78 °C before warming to room
temperature and then stirred for 2 h. The solvent was removed
in vacuo and the dark coloured solid was dissolved in metha-
nol (2 mL). 12 M Hydrochloric acid (0.5 mL) was added and
the mixture stirred for a further 2 h. The solvent was removed
in vacuo to afford a dark solid. Flash column chromatography
(petroleum ether/ethyl acetate, 4 : 1) gave compound 39
(0.04 g, 100%) as a white solid. Mp 164–166 °C; νmax/cm
–1
(neat) 3475 (NH/OH), 2931 (CH), 1698 (CvO), 1500 (CvC),
1380, 1216, 818, 753; δH (400 MHz, CD3OD) 1.13–1.23 (1H, m,
6-HH), 1.86–2.06 (2H, m, 6-HH and 7-HH), 2.14–2.30 (2H, m,
4-HH and 7-HH), 2.58 (1H, dd, J 14.3, 12.5 Hz, 4-HH),
2.87–2.93 (1H, m, 8a-H), 3.41–3.49 (1H, m, 3a-H), 3.59 (1H, t,
J 7.6 Hz, 8b-H), 5.10 (1H, dt, J 10.8, 7.6 Hz, 8-H), 7.21–7.27
(1H, m, ArH), 7.29–7.38 (4H, m, 4 × ArH), 7.40–7.46 (1H, m,
ArH), 7.47–7.58 (4H, m, 4 × ArH); δC (126 MHz, CD3OD)
27.8 (CH2), 30.6 (CH2), 36.2 (CH2), 39.9 (CH), 41.6 (CH),
46.0 (CH), 52.0 (CH), 74.5 (C), 83.7 (C), 92.7 (C), 126.4 (2 × CH),
126.8 (CH), 126.8 (2 × CH), 127.3 (2 × CH), 128.4 (CH), 128.7
(2 × CH), 132.0 (C), 143.5 (C), 162.0 (C), 178.8 (C), 178.8 (C);
m/z (ESI) 559.0564 (MNa+. C25H23
35Cl3N2NaO5 requires
559.0565).
(3aS*,5R*,5aR*,8R*,8aR*,8bR*)-5,5a-Epoxy-2,5-
diphenyl-3a,4,5,5a,6,7,8a,8b-octahydro-8-(2′,2′,2′-
trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (40)
3-Chloroperbenzoic acid (0.03 g, 0.18 mmol) was added
to a stirred solution of (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-
3a,4,6,7,8a,8b-hexahydro-8-(2′,2′,2′-trichloromethylcarbonyl-
amino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (25) (0.02 g,
0.044 mmol) in dichloromethane (2 mL) at 0 °C. The reaction
mixture was warmed from 0 °C to room temperature over 18 h
then cooled to 0 °C before 3-chloroperbenzoic acid (0.03 g,
0.18 mmol) was added. The reaction mixture was stirred for a
further 24 h at room temperature, quenched by the addition of
a saturated solution of sodium sulfite (3 mL) and extracted
with dichloromethane (2 × 3 mL). The combined organic
layers were washed with a saturated solution of sodium hydro-
gen carbonate (3 × 6 mL), water (6 mL), brine (6 mL), then
dried (MgSO4), filtered and concentrated in vacuo. Purification
by flash column chromatography (petroleum ether/diethyl
ether, 1 : 1) gave compound 40 (0.02 g, 65%) as a white solid.
Mp 142–144 °C; νmax/cm
−1 (neat) 3340 (NH), 2921 (CH), 1701
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(CvO), 1514 (CvC), 1390, 1192, 821, 756; δH (400 MHz,
CDCl3) 1.58–1.71 (1H, m, 6-HH), 1.85–1.99 (2H, m, 6-HH and
7-HH), 2.23–2.33 (2H, m, 4-HH and 7-HH), 2.75 (1H, dd, J 9.0,
7.1 Hz, 8a-H), 3.22 (1H, dd, J 15.9, 1.3, 4-HH), 3.40 (1H, dd,
J 9.3, 7.1, 8b-H), 3.49 (1H, td, J 9.3, 1.3 Hz, 3a-H), 5.02–5.13
(1H, m, 8-H), 7.11–7.15 (2H, m, 2 × ArH), 7.21–7.37 (5H, m,
5 × ArH), 7.42–7.55 (3H, m, 3 × ArH), 8.52 (1H, d, J 9.3 Hz,
NH); δC (101 MHz, CDCl3) 25.1 (CH2), 29.5 (CH2), 33.0 (CH2),
38.3 (CH), 40.0 (CH), 45.5 (CH), 52.0 (CH), 61.6 (C), 71.8 (C),
92.7 (C), 126.0 (2 × CH), 126.5 (2 × CH), 128.1 (CH), 128.5
(2 × CH), 129.4 (CH), 129.5 (2 × CH), 131.2 (C), 136.9 (C),
162.0 (C), 178.5 (C), 178.9 (C); m/z (ESI) 541.0450 (MNa+.
C25H21
35Cl3N2NaO4 requires 541.0459).
X-ray procedure for 39
Single crystal diffraction data for 39 were collected by the
EPSRC UK National Crystallography Service.38 Data reduction
was carried out using Crysalis PRO (Agilent Technologies,
2014). The structure was solved by charge-flipping methods
using SuperFlip39 and refined against F2 using full-matrix
least-squares refinement using SHELX201440 within OLEX2.41
Positional and anisotropic atomic displacement parameters
(adps) were refined for all non-hydrogen atoms. Hydrogen
atoms bound to carbon and nitrogen atoms were placed at cal-
culated positions and refined as part of a riding model except
for the MeOH methyl hydrogen and all hydroxyl hydrogen
atoms which located in difference Fourier maps and were
refined as a rigid rotor. There are two independent molecules
of both the compound and of MeOH in the asymmetric unit
although the conformation of the two molecules is essentially
the same.
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